AMCP 2026 (April 13-16)

Biomarker Law Boosted Testing Rates but Gaps Persist Between Insurance Plan Types

George Padron
Oncology Care | Apr 18, 2026
Genentech claims analysis found Illinois biomarker testing law raised odds 1.6x for state-regulated plans, but self-funded plan gaps persisted.

Medicaid Programs Expanded GLP-1 Coverage for New Indications While Narrowing Weight-Loss Access

Sonia Reyes
Medicare/Medicaid Updates, Obesity & Metabolic Health | Apr 16, 2026
IPD Analytics review of state Medicaid FFS programs showed 76% more states listed GLP-1 AOMs on PDLs while weight-loss-only coverage declined.

Branded Drug Costs Hit Low-Income Families Hardest as Benefit Designs Shift Toward Coinsurance

Sonia Reyes
Healthcare Headlines | Apr 15, 2026
J&J analysis of MarketScan and Optum data showed branded drug OOP spending rose 194% from 2014 to 2023, hitting low-income families hardest.